IDH1 and glioblastoma: DEX dose: (1 or 2.5 mg/kg) or high (10 mg/kg)/day. Patients: 181 GBM with IDH wild-type and treated with PD-(L)1 blockade; 75.7% at recurrence and 24.3% in the newly diagnosed setting